Form D — Atsena Therapeutics, Inc.
0001811468-25-000001 · filed 2025-04-11
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $150,000,000
- Total sold
- $89,999,975
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Atsena Therapeutics, Inc.
- CIK
- 1811468
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 8 DAVIS DRIVE, SUITE 300
DURHAM, NC 27709 - Phone
- 984-261-2001
Related persons
-
Patrick Ritschel · Executive OfficerDurham, NC Find on LinkedIn ↗
-
Jennifer Wellman · DirectorDurham, NC Find on LinkedIn ↗
-
Jacqueline Grant · DirectorDurham, NC Find on LinkedIn ↗
-
Chris Carpenter · DirectorDurham, NC Find on LinkedIn ↗
-
Christina Isacson · DirectorDurham, NC Find on LinkedIn ↗
-
Joe Zakrzewski · DirectorDurham, NC Find on LinkedIn ↗
-
Norbert Riedel · DirectorDurham, NC Find on LinkedIn ↗
View original on SEC EDGAR.